Jung-Hyun Kim, Ph.D.
I am a Senior Researcher and Principal Investigator at the Research Institute of the National Cancer Center, South Korea. I earned my Ph.D. in Biomedical Science and Technology from Konkuk University, where my doctoral research focused on mitochondrial apoptosis and MAPK signaling regulated by Bcl-2 family proteins.
I subsequently completed postdoctoral training and held research associate positions at the Mitchell Cancer Institute, University of South Alabama, and the Johns Hopkins University School of Medicine, where I expanded my expertise in cancer biology and molecular regulatory mechanisms.
My research centers on oncogenic RNA splicing and epigenetic regulation associated with treatment resistance in cancer and genetic diseases. I have authored numerous high-impact publications in journals including Nature Communications, Journal of Clinical Investigation, Blood, and Molecular Cell, contributing to the understanding of SON- and HMGA1-mediated transcriptional and splicing networks in tumorigenesis.

Education
2000-2006
Department of Animal Life Science
B.A.
Konkuk University
2006-2012
Ph.D.
Konkuk University
Department of Biomedical Science & Technology
Thesis: Role of Bc1-2 family regulator-mediated MAPK modulation in mitochondria-related apoptosis and cell invasion
Research Experiences
2013-2017
Mitchell Cancer Institute, University of South Alabama
Postdoc Fellow
2017-2019
Mitchell Cancer Institute, University of South Alabama
Research Associate
2019-2022
Department of Hematology, Johns Hopkins University School of Medicine
Research Assocaite
2022 - Present
National Cancer Center (South Korea)
Senior Scientist
(Principal Investigator)
